This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07503/identifier/pubchem-compound/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07503/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07503/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n7http://linked.opendata.cz/resource/drugbank/drug/DB07503/identifier/chemspider/
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n4http://linked.opendata.cz/resource/drugbank/drug/DB07503/identifier/pdb/

Statements

Subject Item
n2:DB07503
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n9:DB07503 n13:DB07503
dcterms:title
(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE
adms:identifier
n4:BYM n7:4450144 n11:5287855 n12:99443974 n14:DB07503
n5:IUPAC-Name
n6:271B4ABF-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4AC5-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4AC4-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4AC1-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4AC2-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4AC3-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4ABD-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4ABB-363D-11E5-9242-09173F13E4C5 n6:271B4ABE-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4ABC-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B4ACB-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4ACC-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4AC6-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4AC7-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4AC9-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4AC8-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4ACA-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4AD1-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4AD3-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4AD4-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4AD0-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4ACF-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4AD2-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4AC0-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4ACD-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4ACE-363D-11E5-9242-09173F13E4C5